Literature DB >> 14568573

The effect of glucocorticoids on the myosin heavy chain isoforms' turnover in skeletal muscle.

Teet Seene1, Priit Kaasik, Ando Pehme, Karin Alev, Eva-Maria Riso.   

Abstract

The purpose of this study was to find the effect of dexamethasone on the myosin heavy chain (MyHC) isoforms' composition in different skeletal muscles and glycolytic (G) fibres in relation with their synthesis rate and degradation of MyHC isoforms by alkaline proteinases. Eighteen-week-old male rats of the Wistar strain were treated with dexamethasone (100 microg/100 g bwt) during 10 days. The forelimb strength decreased from 9.52 to 6.19 N (P<0.001) and hindlimb strength from 15.54 to 8.55 N (P<0.001). Daily motor activity decreased (total activity from 933 to 559 and ambulatory activity from 482 to 226 movements/h, P<0.001). The degradation rate of muscle contractile proteins increased from 2.0 to 5.9% per day (P<0.001), as well as the myosin heavy chain IIB isoform degradation with alkaline proteinase in fast-twitch (F-T) muscles (12 +/- 0.9%; P<0.05) and glycolytic muscle fibres (15 +/- 1.1%; P<0.001). The synthesis rate of MyHC type II isoforms decreased in Pla muscles (P<0.05) and MyHC IIA (P<0.05) and IIB in EDL muscle and G fibres (P<0.001). The relative content of MyHC IIB isoform decreased in F-T muscles (P<0.001) and in G fibres (P<0.01), and the relative content of IIA and IID isoforms increased simultaneously. Dexamethasone decreased the MyHC IIB isoform synthesis rate and increased the sensibility of MyHC IIB isoform to alkaline proteinase, which in its turn led to the decrease of MyHC IIB isoform relative content in F-T muscles with low oxidative potential and G muscle fibres.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568573     DOI: 10.1016/j.jsbmb.2003.08.002

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  9 in total

1.  Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness.

Authors:  Nima Alamdari; Gianluca Toraldo; Zaira Aversa; Ira Smith; Estibaliz Castillero; Guillaume Renaud; Rizwan Qaisar; Lars Larsson; Ravi Jasuja; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-09-26       Impact factor: 3.619

2.  TNF-alpha and glucocorticoid receptor interaction in L6 muscle cells: a cooperative downregulation of myosin heavy chain.

Authors:  Bassem H Dekelbab; Selma F Witchel; Donald B DeFranco
Journal:  Steroids       Date:  2007-06-02       Impact factor: 2.668

Review 3.  The pituitary-adrenal axis and body composition.

Authors:  Eva Fernandez-Rodriguez; Paul M Stewart; Mark S Cooper
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

4.  Role of exercise therapy in prevention of decline in aging muscle function: glucocorticoid myopathy and unloading.

Authors:  Teet Seene; Priit Kaasik
Journal:  J Aging Res       Date:  2012-06-17

5.  Overexpression of Glucocorticoid Receptor β Enhances Myogenesis and Reduces Catabolic Gene Expression.

Authors:  Terry D Hinds; Bailey Peck; Evan Shek; Steven Stroup; Jennifer Hinson; Susan Arthur; Joseph S Marino
Journal:  Int J Mol Sci       Date:  2016-02-11       Impact factor: 5.923

6.  Exercise myopathy: changes in myofibrils of fast-twitch muscle fibres.

Authors:  P Kaasik; M Umnova; T Seene
Journal:  Biol Sport       Date:  2014-07-15       Impact factor: 2.806

Review 7.  Role of Myofibrillar Protein Catabolism in Development of Glucocorticoid Myopathy: Aging and Functional Activity Aspects.

Authors:  Teet Seene; Priit Kaasik
Journal:  Metabolites       Date:  2016-05-13

8.  Changes in Body Composition of Old Rats at Different Time Points After Dexamethasone Administration.

Authors:  Maire Aru; Karin Alev; Ando Pehme; Priit Purge; Lauri Õnnik; Anu Ellam; Priit Kaasik; Teet Seene
Journal:  Curr Aging Sci       Date:  2019

9.  Corticotropin releasing factor-overexpressing mouse is a model of chronic stress-induced muscle atrophy.

Authors:  Wesuk Kang; Tao Tong; Taesun Park
Journal:  PLoS One       Date:  2020-02-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.